ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Topic: lung disease

Three new devices – sealant, coils, one-way valve – may help emphysema patients

Three new devices – sealant, coils, one-way valve – may help emphysema patients

April 13, 2013 4:33 am by | 0 Comments

Three promising lung-shrinking techniques -- coils, one-way valves, and an injectable sealant -- are in or near clinical testing at Temple University and other U.S. medical centers. All three methods ... Read more
Pfizer lung cancer drug gets conditional EU approval

Pfizer lung cancer drug gets conditional EU approval

October 24, 2012 11:30 am by | 0 Comments

Oct 24 (Reuters) - European health regulators granted conditional approval to Pfizer Inc's Xalkori to treat advanced non-small cell lung cancer in patients with a specific genetic mutation, the company ... Read more
Actelion: 10 mg of lung drug Opsumit for pulmonary hypertension reduces mortality by 36%

Actelion: 10 mg of lung drug Opsumit for pulmonary hypertension reduces mortality by 36%

October 24, 2012 1:39 am by | 0 Comments

ZURICH (Reuters) - Actelion's experimental lung drug macitentan prolonged overall survival by more than a third according to detailed study data, which the company hopes will convince investors it has ... Read more
Bayer lung drug shows promise in pulmonary hypertension

Bayer lung drug shows promise in pulmonary hypertension

October 22, 2012 12:01 am by | 0 Comments

FRANKFURT (Reuters) - Bayer's experimental riociguat pill showed promise against a life-threatening form of high blood pressure in the lungs, a potential challenge to existing treatments from Actelion and Gilead.In ... Read more
Lung transplant device could improve chances for success (and more lungs)

Lung transplant device could improve chances for success (and more lungs)

October 9, 2012 7:43 pm by | 0 Comments

LONDON (Reuters) - Scientists have successfully tested a portable device to prepare lungs for transplant, potentially boosting the number of organs available and reducing the risk the operation will fail.The ... Read more
Canadian health regulators approve InterMune’s pulmonary fibrosis drug

Canadian health regulators approve InterMune’s pulmonary fibrosis drug

October 2, 2012 6:08 pm by | 0 Comments

(Reuters) - Biotechnology company InterMune Inc said Canadian health regulators approved its drug to treat idiopathic pulmonary fibrosis, a fatal lung disease.InterMune expects the drug Esbriet, chemically known as pirfenidone, ... Read more
Microwave popcorn maker, grocery ordered to pay Colorado man $7.2 million in lung disease lawsuit

Microwave popcorn maker, grocery ordered to pay Colorado man $7.2 million in lung disease lawsuit

September 19, 2012 8:01 pm by | 4 Comments

DENVER (Reuters) - A federal court jury on Wednesday awarded a Colorado man $7.2 million in damages for developing a chronic condition known as popcorn lung from a chemical used ... Read more
Small trial shows Peregrine’s experimental lung cancer drug helps patients live longer

Small trial shows Peregrine’s experimental lung cancer drug helps patients live longer

September 9, 2012 11:30 am by | 0 Comments

(Reuters) - A mid-stage trial of Peregrine Pharmaceuticals Inc's experimental drug bavituximab showed that it doubled the length of time lung cancer patients survived, supporting the company's plans to conduct ... Read more
Fundraising: California medical device startup treating hypertension raises $6 million

Fundraising: California medical device startup treating hypertension raises $6 million

August 17, 2012 2:37 pm by | 2 Comments

California startup Rox Medical, which makes an implanted medical device to treat severe chronic obstructive pulmonary disease, has raised $5 million in search of $9 million. ... Read more
BMY partners with Duke University on clinical trial for lung disease drug

BMY partners with Duke University on clinical trial for lung disease drug

February 29, 2012 11:24 am by | 0 Comments

A Bristol-Myers Squibb (NYSE:BMY) lung disease drug candidate is moving ahead in clinical development under a new partnership with Duke University.Under the alliance, Bristol-Myers scientists will work with the Duke ... Read more
Regenerative medicine for lung disease focus of $2.5 million Penn grant

Regenerative medicine for lung disease focus of $2.5 million Penn grant

January 18, 2012 6:16 pm by | 0 Comments

A study exploring lung repair and tissue regeneration to fight lung diseases by a team at the Perelman School of Medicine at the University of Pennsylvania in Philadelphia has received ... Read more